This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.88% higher to $649.32 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.17% to 4,690.70 and the Dow Jones Industrial Average rising 0.55% to 35,813.80. Regeneron Pharmaceuticals Inc. closed $37.30 below its 52-week high ($686.62), which the company reached on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.62% to $160.69, Novartis AG ADR (NOVN.EB) rose 1.66% to $82.67, and Amgen Inc. (AMGN) rose 0.89% to $204.53. Trading volume (624,295) remained 137,595 below its 50-day average volume of 761,890.
Data source: Dow Jones Market Data, FactSet. Data compiled November 23, 2021.
(END) Dow Jones Newswires
November 23, 2021 17:19 ET (22:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.